The purpose of this study is to see if Zemplar, a vitamin D medication, safely and effectively decreases parathyroid hormone in children ages 2-20 with End Stage Renal Disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
28
Stanford University Medical Center
Stanford, California, United States
Miami Children's Hospital
Miami, Florida, United States
The Children's Hospital of Buffalo
Buffalo, New York, United States
Texas Children's Hospital
Houston, Texas, United States
Proportion of subjects achieving at least a 30% decrease from baseline iPTH sustained for at least two consecutive iPTH measurements.
Proportion of subjects in each group who achieve two consecutive iPTH values below 300 pg/mL.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Texas at Houston
Houston, Texas, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States